Recombinant Vaccinia virus Glutaredoxin-2 (MVA073L, ACAM3000_MVA_073)

What is Vaccinia virus Glutaredoxin-2 and how does it differ from other viral glutaredoxins?

Vaccinia virus Glutaredoxin-2 (MVA073L, ACAM3000_MVA_073) is a 124-amino acid protein encoded by the G4L gene of Vaccinia virus (strain Ankara) . It belongs to the glutaredoxin family, which functions as thioltransferases that use glutathione as a cofactor for the reduction of disulfides in both prokaryotes and eukaryotes .

Vaccinia virus encodes two distinct glutaredoxins: G4L (Glutaredoxin-2) and O2L (Glutaredoxin-1), which despite sharing similar in vitro enzymatic activities, have significantly different biological functions . The key differences include:

While both proteins exhibit thioltransferase and dehydroascorbate reductase activities in vitro, G4L is essential for viral replication, whereas O2L is dispensable . This suggests that Glutaredoxin-2 serves a critical role in the virus life cycle beyond what can be compensated by other redox enzymes.

What enzymatic activities are associated with Vaccinia virus Glutaredoxin-2?

Vaccinia virus Glutaredoxin-2 demonstrates multiple enzymatic activities that are characteristic of the glutaredoxin family:

• Thioltransferase activity: Glutaredoxin-2 catalyzes thiol-disulfide exchange reactions, which are critical for maintaining the proper redox state of proteins .

• Dehydroascorbate reductase activity: The protein can reduce dehydroascorbate to ascorbate (vitamin C), potentially contributing to antioxidant defense mechanisms within the infected cell .

These enzymatic activities have been confirmed through in vitro studies using both virion-derived protein and recombinant forms expressed in Escherichia coli . Unlike Glutaredoxin-1 (O2L), which serves as a cofactor for viral ribonucleotide reductase in deoxyribonucleotide synthesis, Glutaredoxin-2 appears to utilize its redox capabilities primarily in the context of virion assembly and maturation .

What are the recommended methods for expression and purification of recombinant Vaccinia virus Glutaredoxin-2?

Based on established research protocols, recombinant Vaccinia virus Glutaredoxin-2 can be effectively expressed and purified using the following methodological approach:

• Expression system selection: E. coli expression systems have been successfully employed for the production of functional recombinant Glutaredoxin-2 . The bacterial expression approach offers advantages in terms of yield and ease of genetic manipulation.

• Gene optimization: The G4L gene sequence should be codon-optimized for the chosen expression system to enhance protein production.

• Vector design: Incorporate appropriate affinity tags (His-tag or GST-tag) to facilitate purification while ensuring they don't interfere with protein folding or activity.

• Expression conditions: Induce protein expression at lower temperatures (16-20°C) to promote proper folding of the redox-active protein.

• Purification protocol:

  • Initial capture using affinity chromatography (Ni-NTA for His-tagged constructs)

  • Intermediate purification via ion exchange chromatography

  • Final polishing step using size exclusion chromatography

• Protein quality assessment:

  • SDS-PAGE and Western blotting to confirm identity and purity

  • Enzymatic activity assays (thioltransferase and dehydroascorbate reductase) to verify functionality

  • Circular dichroism to assess proper folding

This methodology can be adapted depending on the specific research application and required protein characteristics.

How can researchers accurately measure the thioltransferase activity of Glutaredoxin-2?

Accurate measurement of thioltransferase activity of Glutaredoxin-2 requires careful attention to redox conditions and appropriate assay selection. The following methodological approach is recommended:

• Standard HEDS assay (2-hydroxyethyl disulfide reduction):

  • Prepare reaction mixture containing glutathione, glutathione reductase, NADPH, and HEDS

  • Add purified Glutaredoxin-2 to initiate the reaction

  • Monitor the decrease in NADPH absorbance at 340 nm spectrophotometrically

  • Calculate activity based on the rate of NADPH oxidation

• Insulin disulfide reduction assay:

  • Mix insulin with DTT buffer in the presence of Glutaredoxin-2

  • Monitor the increase in turbidity at 650 nm as insulin B-chain precipitates upon reduction

  • Compare rates with control reactions lacking glutaredoxin

• Redox-sensitive fluorescent protein substrates:

  • Utilize engineered fluorescent proteins containing disulfide bonds

  • Measure fluorescence changes as disulfides are reduced by Glutaredoxin-2

  • Provides real-time, high-sensitivity measurements

Critical considerations include:

• Maintaining strict anaerobic conditions during assay preparation

• Ensuring all buffers are degassed to prevent oxygen interference

• Including appropriate positive controls (purified E. coli or human glutaredoxins)

• Normalizing activity to protein concentration

Specific activity should be expressed as μmol substrate reduced per minute per mg protein under standardized conditions .

What is the role of Glutaredoxin-2 in Vaccinia virus morphogenesis?

Glutaredoxin-2 plays a critical role in Vaccinia virus morphogenesis, with substantial evidence indicating its involvement in virion assembly and maturation. Research utilizing conditional lethal recombinant viruses has revealed several key aspects of its function:

• Temporal expression pattern: Glutaredoxin-2 is expressed at late times after infection, which coincides with the assembly phase of the viral replication cycle .

• Virion incorporation: The protein is physically incorporated into both immature and mature virions, as demonstrated by immunogold labeling techniques .

• Essential nature: Unlike Glutaredoxin-1 (O2L), Glutaredoxin-2 is essential for virus replication. Attempts to isolate mutant viruses with deleted G4L genes have been unsuccessful, confirming its critical role .

• Morphogenesis defects in absence of G4L: When G4L expression is suppressed in conditional mutants:

  • Production of infectious virus is severely inhibited

  • Viral late protein synthesis appears largely unaffected

  • Decreased maturation-dependent proteolytic processing of certain core components occurs

  • Electron microscopy reveals accumulation of crescent membranes on the periphery of electron-dense globular masses

  • Few mature viral particles are observed

• Proposed mechanism: Glutaredoxin-2 likely functions as a redox protein during virion morphogenesis, potentially:

  • Catalyzing the formation or rearrangement of disulfide bonds in viral structural proteins

  • Ensuring proper folding of viral proteins during assembly

  • Facilitating membrane restructuring processes required for virion maturation

This essential role in morphogenesis explains why G4L is highly conserved across poxvirus genera, including Molluscum contagiosum virus, Shope rabbit fibroma virus, Myxoma virus, Fowlpoxvirus, and entomopoxviruses .

How does the function of Glutaredoxin-2 (G4L) differ from Glutaredoxin-1 (O2L) in Vaccinia virus?

Despite sharing similar enzymatic activities in vitro, Glutaredoxin-2 (G4L) and Glutaredoxin-1 (O2L) serve distinctly different functions in the Vaccinia virus life cycle, highlighting the specialized roles of these redox proteins:

The distinct functions of these two glutaredoxins demonstrate how viruses can adapt similar enzyme scaffolds for specialized roles. While O2L primarily functions in metabolic pathways related to DNA synthesis, G4L has evolved a critical structural role in the assembly of infectious virions . The late expression of O2L, which is atypical for enzymes involved in DNA precursor biosynthesis, suggests it may have additional, currently unknown functions beyond serving as a cofactor for ribonucleotide reductase .

What experimental approaches are recommended for studying the structural determinants of Glutaredoxin-2 activity?

Investigating the structural determinants of Vaccinia virus Glutaredoxin-2 activity requires a multifaceted approach combining structural biology, molecular biology, and biochemical techniques:

• X-ray crystallography:

  • Express and purify recombinant Glutaredoxin-2 to high homogeneity

  • Screen for crystallization conditions using sitting or hanging drop vapor diffusion

  • Collect diffraction data at synchrotron radiation facilities

  • Solve structure using molecular replacement with known glutaredoxin structures

  • Identify active site architecture and key structural elements

• Site-directed mutagenesis:

  • Target conserved cysteine residues in the active site

  • Create alanine scanning mutants across predicted functional domains

  • Generate chimeric proteins between G4L and O2L to identify domains responsible for their functional differences

  • Express and purify mutant proteins for activity testing

• Enzymatic characterization:

  • Compare thioltransferase and dehydroascorbate reductase activities of wild-type and mutant proteins

  • Determine kinetic parameters (Km, kcat, kcat/Km) for different substrates

  • Analyze pH and temperature optima for enzymatic activities

  • Assess cofactor requirements and binding affinities

• Protein-protein interaction studies:

  • Employ pull-down assays using tagged recombinant Glutaredoxin-2

  • Conduct yeast two-hybrid screens to identify viral and host interaction partners

  • Validate interactions using surface plasmon resonance or isothermal titration calorimetry

  • Map interaction surfaces through hydrogen-deuterium exchange mass spectrometry

• NMR spectroscopy:

  • Prepare isotopically labeled protein for structural analysis

  • Record multidimensional NMR spectra to assess protein dynamics

  • Monitor chemical shift perturbations upon substrate binding

  • Characterize conformational changes associated with catalytic activity

These complementary approaches will provide insights into how the structure of Glutaredoxin-2 determines its specialized function in virion morphogenesis, potentially identifying critical regions that could be targeted for antiviral development.

How can researchers design conditional knockout systems to study essential viral proteins like Glutaredoxin-2?

Designing effective conditional knockout systems for essential viral proteins like Glutaredoxin-2 requires sophisticated genetic engineering approaches. Based on successful strategies used in previous studies , researchers should consider the following methodological framework:

• Inducible expression system design:

  • Replace the native G4L promoter with an inducible promoter (e.g., tetracycline-responsive or IPTG-inducible)

  • Include a selectable marker for recombinant virus isolation

  • Ensure minimal leaky expression in the uninduced state

  • Validate that maximum induction produces physiological or higher protein levels

• Homologous recombination strategy:

  • Create a transfer plasmid containing:

    • Flanking regions homologous to sequences surrounding the G4L gene

    • The G4L coding sequence under inducible promoter control

    • Selectable marker (e.g., antibiotic resistance or fluorescent protein)

  • Transfect the plasmid into cells infected with wild-type virus

  • Select recombinant viruses through marker expression or plaque phenotype

• Verification of conditional expression:

  • Perform RNase protection or RT-qPCR assays to quantify G4L transcript levels

  • Use Western blotting to confirm protein expression is proportional to inducer concentration

  • Establish a titration curve correlating inducer concentration with protein expression levels

  • Validate that protein function can be varied from barely detectable to above normal levels

• Phenotypic characterization:

  • Assess virus replication under permissive and non-permissive conditions

  • Quantify infectious virus production at different inducer concentrations

  • Analyze viral protein synthesis patterns, especially late gene expression

  • Examine virion morphogenesis using electron microscopy

  • Evaluate maturation-dependent proteolytic processing of viral core components

• Rescue experiments:

  • Complement the conditional knockout with wild-type or mutant G4L expressed from a different locus

  • Test heterologous glutaredoxins for functional complementation

  • Utilize trans-complementing cell lines expressing G4L to validate specificity

This approach allows precise temporal control over protein expression, enabling the study of essential proteins at different stages of the viral life cycle while avoiding the selection problems inherent in attempting to isolate null mutants of essential genes .

What are the major technical challenges in studying redox-active proteins like Glutaredoxin-2 in viral systems?

Investigating redox-active proteins like Glutaredoxin-2 in viral systems presents several unique technical challenges that researchers must address with specialized methodological approaches:

• Maintaining redox state integrity:

  • Challenge: Redox-active proteins are highly sensitive to oxidation during isolation and analysis

  • Solution: Perform all purification steps under anaerobic conditions or with reducing agents

  • Methodology: Use sealed chambers with inert gas, include DTT or reduced glutathione in buffers, and minimize sample exposure to air

• Distinguishing viral from host redox activities:

  • Challenge: Host cells contain multiple glutaredoxins and thioredoxins with overlapping functions

  • Solution: Develop specific antibodies or tagged viral proteins for selective monitoring

  • Methodology: Create cell lines with reduced host glutaredoxin expression or use CRISPR/Cas9 to modify host redox systems

• Preserving native disulfide bonding patterns:

  • Challenge: Artificial oxidation can create non-native disulfide bonds during analysis

  • Solution: Employ rapid alkylation techniques to trap native redox states

  • Methodology: Use iodoacetamide or N-ethylmaleimide to block free thiols before protein denaturation

• Tracking dynamic redox changes during infection:

  • Challenge: Redox states change dynamically throughout the viral life cycle

  • Solution: Develop real-time redox sensors for live-cell imaging

  • Methodology: Engineer redox-sensitive fluorescent proteins like roGFP into viral or cellular proteins

• Reconstituting physiologically relevant conditions in vitro:

  • Challenge: In vitro assays may not reflect the complex cellular environment

  • Solution: Develop more sophisticated assay systems incorporating native substrates

  • Methodology: Utilize membrane fractions, partially purified viral assembly complexes, or cell-free virion assembly systems

• Differentiating between direct and indirect effects:

  • Challenge: Determining whether morphogenesis defects are directly caused by lack of G4L activity

  • Solution: Separate enzymatic activity from structural functions through carefully designed mutants

  • Methodology: Create catalytically inactive mutants that retain structural integrity and test for complementation

Addressing these challenges requires interdisciplinary approaches combining virology, redox biochemistry, and advanced imaging techniques to fully understand the complex roles of viral glutaredoxins .

What are the potential applications of Vaccinia virus Glutaredoxin-2 in biotechnology and experimental virology?

Vaccinia virus Glutaredoxin-2 presents several promising applications in biotechnology and experimental virology based on its unique properties and essential role in poxvirus biology:

• Antiviral drug development:

  • Target identification: As an essential viral protein with no direct human homolog, Glutaredoxin-2 represents an attractive target for selective antiviral therapy

  • High-throughput screening: Develop assays measuring thioltransferase activity to screen compound libraries for specific inhibitors

  • Structure-based drug design: Utilize structural data to design small molecules that selectively inhibit viral glutaredoxin activity

  • Potential applications against multiple poxviruses due to high conservation of G4L across genera

• Biotechnological applications:

  • Protein folding enhancement: Exploit the disulfide isomerase activity to improve recombinant protein production

  • Redox sensor development: Engineer modified versions as sensitive detectors for redox conditions in biological systems

  • Enzyme stabilization: Apply insights from viral glutaredoxin stability to improve industrial enzyme performance

• Vaccine vector development:

  • Attenuated vectors: Create conditionally replicating vaccinia vectors by modifying G4L regulation

  • Safety improvements: Engineer compensatory mechanisms for G4L to enhance safety of vaccinia-based vaccines

  • Immunogenicity modulation: Modify virion structure through controlled G4L expression to alter adaptive immune responses

• Experimental virology tools:

  • Viral assembly research: Use G4L-dependent systems to synchronize and study discrete steps in poxvirus morphogenesis

  • Protein tagging: Develop G4L fusion proteins as markers for viral assembly compartments

  • Controlled virus production: Implement inducible G4L expression systems for precise regulation of virus yields

• Fundamental research applications:

  • Comparative virology: Study the evolutionary adaptations of redox systems across different virus families

  • Host-pathogen interactions: Investigate the interplay between viral and cellular redox systems during infection

  • Protein structure-function relationships: Explore how similar enzyme scaffolds evolve different specialized functions

These diverse applications highlight the potential of Vaccinia virus Glutaredoxin-2 to contribute to both basic science and translational research fields .

How does Vaccinia virus Glutaredoxin-2 compare to glutaredoxins from other virus families?

Vaccinia virus Glutaredoxin-2 (G4L) exhibits both similarities and notable differences when compared to glutaredoxins from other viral families, reflecting diverse evolutionary adaptations:

While most viruses rely on host cell redox systems, poxviruses have evolved to encode their own glutaredoxins with specialized functions. The essential nature of G4L for virus replication, combined with its high conservation across poxvirus genera including Molluscum contagiosum virus, Shope rabbit fibroma virus, Myxoma virus, Fowlpoxvirus, and entomopoxviruses, suggests it plays a fundamental role in the poxvirus life cycle that cannot be complemented by host factors .

This specialization likely reflects the cytoplasmic replication strategy of poxviruses, which may necessitate virus-encoded redox systems to function in specialized viral factories where host factors may be limited or insufficient for the complex assembly process of these large DNA viruses.

What insights can structural comparisons between viral and cellular glutaredoxins provide for understanding functional specialization?

Structural comparisons between viral and cellular glutaredoxins offer valuable insights into the molecular basis of functional specialization and evolutionary adaptation:

• Core structural fold conservation:

  • Vaccinia virus Glutaredoxin-2 maintains the canonical glutaredoxin fold (βαβαββα) seen in cellular counterparts

  • This structural conservation despite sequence divergence highlights the robustness of the glutaredoxin scaffold

  • The preservation of this fold suggests strong selective pressure to maintain redox functionality

• Active site modifications:

  • Viral glutaredoxins typically preserve the CXXC active site motif critical for catalytic activity

  • Subtle variations in the XX residues may tune substrate specificity and reaction kinetics

  • Vaccinia Glutaredoxin-2 likely contains specific active site adaptations that facilitate its role in virion morphogenesis

• Surface property adaptations:

  • Alterations in surface charge distribution between viral and cellular glutaredoxins

  • These modifications likely mediate specific protein-protein interactions with viral structural components

  • Such adaptations would explain why cellular glutaredoxins cannot functionally substitute for G4L

• Substrate binding pocket specialization:

  • Differences in substrate recognition regions explain functional divergence

  • Vaccinia Glutaredoxin-2 may have evolved to preferentially interact with viral proteins containing specific disulfide patterns

  • These specializations could direct the protein toward structural roles rather than typical metabolic functions

• Dimer formation and quaternary structure:

  • Some glutaredoxins function as dimers or as components of larger complexes

  • Structural features controlling oligomerization could differ between viral and cellular glutaredoxins

  • Vaccinia Glutaredoxin-2 may have unique dimerization properties related to its association with virion components

• Integration with virion architecture:

  • Specific structural elements likely evolved to facilitate incorporation into the complex virion structure

  • These features would be absent in cellular glutaredoxins with primarily metabolic functions

  • Such adaptations explain the essential nature of G4L in virion morphogenesis

These structural insights provide a foundation for understanding how a conserved enzyme scaffold has been repurposed through evolution for specialized roles in viral replication, potentially informing both fundamental virology research and antiviral development strategies targeting these unique viral-specific features .

What are the key unresolved questions about Vaccinia virus Glutaredoxin-2 that warrant further investigation?

Several critical questions about Vaccinia virus Glutaredoxin-2 remain unresolved, presenting important opportunities for future research:

• Precise mechanisms in virion morphogenesis:

  • What specific substrates does Glutaredoxin-2 act upon during virion assembly?

  • Are its functions primarily catalytic (redox-related) or structural?

  • How does it contribute to the complex multi-step process of poxvirus morphogenesis?

  • What are the specific disulfide bond formations or rearrangements mediated by G4L?

• Protein interaction network:

  • What viral and/or host proteins directly interact with Glutaredoxin-2?

  • How is G4L recruited to sites of virion assembly?

  • Does it function as part of a larger redox-regulatory complex?

  • Are these interactions dependent on the redox state of the protein?

• Regulation of activity:

  • How is the activity of Glutaredoxin-2 regulated during infection?

  • Are there post-translational modifications that affect its function?

  • Does the protein undergo conformational changes during the viral life cycle?

  • How does the cellular redox environment influence its activity?

• Evolutionary aspects:

  • Why have poxviruses maintained two distinct glutaredoxins with different functions?

  • What selective pressures drove the specialization of G4L for morphogenesis?

  • How do glutaredoxins from different poxvirus genera differ functionally?

  • Can these differences explain host range or tissue tropism variations?

• Therapeutic potential:

  • Can small molecule inhibitors specifically targeting G4L be developed as antivirals?

  • Would targeting G4L lead to resistance, and through what mechanisms?

  • Could modified forms of G4L be used to create attenuated viral vectors?

  • Are there host-directed therapies that could interfere with G4L function?

• Structural biology:

  • What is the three-dimensional structure of Glutaredoxin-2?

  • How does its structure compare to Glutaredoxin-1 (O2L) and cellular glutaredoxins?

  • What structural features enable its incorporation into virions?

  • Are there unique structural elements that explain its essential nature?

Addressing these questions will require interdisciplinary approaches combining structural biology, biochemistry, genetics, and advanced imaging techniques to fully elucidate the complex roles of this essential viral protein .

What methodological advances would facilitate more detailed studies of redox-dependent processes in poxvirus morphogenesis?

Advancing our understanding of redox-dependent processes in poxvirus morphogenesis requires innovative methodological approaches that can overcome current technical limitations:

• Real-time redox imaging in living cells:

  • Development of genetically encoded redox sensors incorporated into viral proteins

  • Application of advanced microscopy techniques such as FRET-based sensors to track redox changes during infection

  • Integration of super-resolution microscopy with redox probes to visualize redox microenvironments in viral assembly sites

  • Implementation of light-sheet microscopy for long-term imaging of redox dynamics with minimal phototoxicity

• Redox proteomics advancements:

  • Refinement of techniques to preserve native redox states during sample preparation

  • Application of isotope-coded affinity tags specific for thiol groups to quantify redox changes

  • Development of targeted proteomics approaches for low-abundance viral proteins

  • Integration of top-down proteomics to characterize intact viral proteins with post-translational modifications

• Genetic systems for studying essential viral functions:

  • Creation of rapidly inducible/repressible gene expression systems with minimal leakage

  • Development of split-protein complementation systems for real-time monitoring of protein interactions

  • Implementation of CRISPR interference for temporal control of gene expression

  • Design of synthetic viral genomes with orthogonal redox systems

• In vitro reconstitution systems:

  • Development of cell-free systems that recapitulate aspects of virion assembly

  • Creation of artificial membrane systems mimicking viral assembly sites

  • Reconstitution of minimal protein sets required for specific morphogenesis steps

  • Application of microfluidic devices to study assembly processes under controlled conditions

• Computational and structural approaches:

  • Integration of molecular dynamics simulations to predict redox-dependent conformational changes

  • Application of machine learning to identify patterns in high-dimensional redox imaging data

  • Development of in silico models predicting disulfide bond formation during virion assembly

  • Implementation of hybrid structural biology approaches combining crystallography, cryo-EM, and mass spectrometry

• Single-virion analysis technologies:

  • Development of techniques to assess redox status in individual viral particles

  • Application of nanoscale secondary ion mass spectrometry to map elemental distribution

  • Implementation of correlative light and electron microscopy specifically adapted for redox imaging

  • Creation of microfluidic sorting systems for virions based on redox properties

These methodological advances would enable researchers to address fundamental questions about how redox processes, mediated by proteins like Glutaredoxin-2, contribute to the complex assembly pathway of poxviruses, potentially revealing new targets for antiviral intervention .